Residual Inflammation and Plaque Progression Long-term Evaluation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inflammation drives atherosclerotic plaque rupture triggering most acute coronary syndromes. Despite advances in diagnosis and management of atherosclerosis, patients with myocardial infarction (MI) remain at increased risk of recurrent events. The RIPPLE study aims to examine the relationship between residual coronary inflammation detected by 68Ga-DOTATATE PET in patients treated for MI to long-term plaque progression measured by CT coronary angiography (CTCA). The association between infarct-related myocardial 68Ga-DOTATATE PET and myocardial function and viability will also be assessed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

NCT07104487

Stroke (CVA) or TIA Carotid Artery Plaque Atherosclerosis Cardiovascular Disease +1 more

RECRUITING PHASE2

Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography

NCT02021188

Atherosclerosis Stroke Transient Ischemic Attack +2 more

COMPLETED

PET-MR Imaging of Coronary Atherothrombosis

NCT03618303

Heart Diseases, Ischemic

COMPLETED NA

Magnetic Resonance Imaging (MRI) Analysis of Coronary Artery Plaque Components

NCT00559728

Coronary Artery Plaque Components

COMPLETED

Atherosclerotic Plaque Characterization

NCT00861653

Atherosclerosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While vascular inflammation can be detected using 18F-FDG PET, this method lacks inflammatory cell specificity and is unreliable for coronary imaging because of high background signals from the myocardium. Upregulation of somatostatin receptor subtype-2 (SST2) occurs in activated macrophages, offering a novel inflammation imaging target. 68Ga-DOTATATE, an SST2 PET tracer with low myocardial binding, shows promise for imaging coronary inflammation. Having previously demonstrated increased 68Ga-DOTATATE signals in coronary atherosclerotic lesions post-MI, we now aim to study the natural history of residual arterial inflammation in non-culprit arteries and better understand how 68Ga-DOTATATE signals relate to plaque morphology, progression and rupture. Residual infarct-related myocardial inflammation and its association with ischemic myocardial remodelling will also be examined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atherosclerosis Myocardial Infarction Coronary Artery Disease Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.